Osaic Holdings’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
1,503
+1,486
+8,741% +$33.2K ﹤0.01% 6205
2026
Q1
$441 Sell
17
-14
-45% -$1.76K ﹤0.01% 7459
2025
Q4
$7.67K Sell
31
-322
-91% -$73.5K ﹤0.01% 6484
2025
Q3
$70.1K Buy
353
+1
+0.3% +$176 ﹤0.01% 5078
2025
Q2
$34.6K Buy
352
+8
+2% +$698 ﹤0.01% 5307
2025
Q1
$30.2K Buy
344
+1
+0.3% +$92 ﹤0.01% 5075
2024
Q4
$24.7K Buy
343
+326
+1,918% +$22.3K ﹤0.01% 5194
2024
Q3
$1.33K Hold
17
– – ﹤0.01% 6749
2024
Q2
$1.22K Buy
17
+11
+183% +$658 ﹤0.01% 6758
2024
Q1
$529 Buy
6
+1
+20% +$88 ﹤0.01% 6803
2023
Q4
$359 Sell
5
-3
-38% -$177 ﹤0.01% 6941
2023
Q3
$499 Buy
8
+4
+100% +$369 ﹤0.01% 6988
2023
Q2
$360 Sell
4
-7
-64% -$697 ﹤0.01% 7114
2023
Q1
$1.08K Buy
11
+3
+38% +$459 ﹤0.01% 6929
2022
Q4
$2K Buy
8
+4
+100% +$2.63K ﹤0.01% 6652
2022
Q3
$5K Hold
4
– – ﹤0.01% 6357
2022
Q2
$3K Sell
4
-33
-89% -$20.5K ﹤0.01% 6721
2022
Q1
$26K Sell
37
-13
-26% -$10K ﹤0.01% 5521
2021
Q4
$45K Sell
50
-2
-4% -$1.9K ﹤0.01% 5229
2021
Q3
$52K Buy
52
+7
+16% +$5.16K ﹤0.01% 5064
2021
Q2
$29K Buy
45
+30
+200% +$20.8K ﹤0.01% 5419
2021
Q1
$11K Hold
15
– – ﹤0.01% 5820
2020
Q4
$12K Sell
15
-3
-17% -$2.36K ﹤0.01% 5431
2020
Q3
$17K Buy
18
+6
+50% +$6.36K ﹤0.01% 4998
2020
Q2
$12K Buy
12
+1
+9% +$1.01K ﹤0.01% 5088
2020
Q1
$9K Buy
+11
New +$11.5K ﹤0.01% 5061

Other funds holding GOSS

Osaic Holdings's GOSS Position: Q2 2026 in Review

Osaic Holdings increased its Gossamer Bio (GOSS) stake by 8,741% in Q2 2026, buying an estimated $33.2K and bringing the position to 1,503 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6205.

Osaic Holdings first reported a position in GOSS in Q1 2020 and has held it in 26 quarters since. The position peaked at $70.1K in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Osaic Holdings held 1,503 shares of Gossamer Bio worth $19.2K as of Q2 2026.
  • Osaic Holdings bought 1,486 Gossamer Bio shares in Q2 2026, an estimated $33.2K.
  • Gossamer Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6205 holding.
  • Osaic Holdings first reported a position in Gossamer Bio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Gossamer Bio position peaked at $70.1K in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.